PRESS RELEASE published on 06/02/2026 at 07:30, 22 days ago Inventiva annonce la suspension temporaire du cours de ses actions ordinaires sur Euronext Paris Inventiva annonce la suspension temporaire du cours de ses actions ordinaires sur Euronext Paris en raison d'un projet d'opération de financement. Les négociations devraient reprendre le 2 juin 2026 Euronext Paris Financement Inventiva NATiV3 Suspension Temporaire
PRESS RELEASE published on 06/02/2026 at 07:30, 22 days ago Inventiva Announces Temporary Trading Halt of its Ordinary Shares on Euronext Paris Inventiva announces temporary trading halt of its ordinary shares on Euronext Paris for a proposed financing transaction. Trading to resume after communication Euronext Paris Trading Halt Clinical Trial Inventiva Metabolic Dysfunction
BRIEF published on 05/26/2026 at 22:05, 28 days 10 hours ago Inventiva Annonce ses Résultats Financiers du Premier Trimestre 2026 Résultats Financiers Biopharmaceutique Trésorerie Inventiva NATiV3
BRIEF published on 05/26/2026 at 22:05, 28 days 10 hours ago Inventiva Announces its First Quarter 2026 Financial Results Financial Results Treasury Biopharmaceutical Inventiva NATiV3
PRESS RELEASE published on 05/26/2026 at 22:00, 28 days 10 hours ago Inventiva publie ses informations financières du premier trimestre 2026¹ Inventiva publie ses informations financières du premier trimestre 2026, montrant une trésorerie de 75 millions d'euros et des dépôts à court terme de 121,5 millions d'euros Trésorerie Inventiva Trimestre 2026 Dépôts À Court Terme Équivalents De Trésorerie
PRESS RELEASE published on 05/26/2026 at 22:00, 28 days 10 hours ago Inventiva Reports 2026 First Quarter Financial Information¹ Inventiva reports first quarter 2026 financial information, with cash and cash equivalents at €75.0 million and short-term deposits at €121.5 million. Explore company's financial results and upcoming milestones Financial Information Inventiva NATiV3 Cash Equivalents Short-term Deposits
BRIEF published on 05/21/2026 at 22:05, 1 month 2 days ago Inventiva at the 2026 Jefferies Global Healthcare Conference Biopharmaceutical Inventiva MASH Lanifibranor Jefferies Conference
BRIEF published on 05/21/2026 at 22:05, 1 month 2 days ago Inventiva présentera ses travaux lors de la conférence mondiale Jefferies sur les soins de santé 2026. Biopharmaceutique Inventive Conférence Jefferies Lanifibranor Traitement MASH
BRIEF published on 05/21/2026 at 22:05, 1 month 2 days ago Inventiva to Present at 2026 Jefferies Global Healthcare Conference Biopharmaceutical Inventiva Lanifibranor MASH Treatment Jefferies Conference
BRIEF published on 05/21/2026 at 22:05, 1 month 2 days ago Inventiva à la 2026 Jefferies Global Healthcare Conference Biopharmaceutique Inventiva Conférence Jefferies MASH Lanifibranor
Published on 06/24/2026 at 03:15, 4 hours 56 minutes ago Noram Lithium Adopts Semi-Annual Financial Reporting
Published on 06/24/2026 at 00:00, 8 hours 11 minutes ago Onco-Innovations Engages Nanosoft Polymers to Advance Polymer and Drug Delivery Development for ONC010
Published on 06/23/2026 at 23:45, 8 hours 26 minutes ago Prospect Ridge Aligns with the Market Mindset for Exclusive Live Investor Interview Discussing Game-changing 2026 Drill Programs
Published on 06/23/2026 at 23:20, 8 hours 51 minutes ago BioNxt Announces Closing of Non-brokered Private Placement of Units Pursuant to the Listed Issuer Exemption
Published on 06/23/2026 at 23:15, 8 hours 56 minutes ago EV Nickel Signs LOI Forming High-Grade Nickel Joint Venture for Shaw Dome Projects
Published on 06/24/2026 at 08:00, 11 minutes ago Fuller, Smith & Turner PLC: Director/PDMR Shareholdings
Published on 06/24/2026 at 08:00, 11 minutes ago EUROPLASMA: Assemblée générale ordinaire et extraordinaire des actionnaires le 30 juillet 2026
Published on 06/24/2026 at 07:59, 11 minutes ago HEIDELBERG integrates the lifecycle business and global sales and service companies of the manroland sheetfed Group
Published on 06/24/2026 at 07:59, 11 minutes ago LEG Immobilien SE: Shareholders reinvest EUR 63.1 million through scrip dividend — 28.6% acceptance rate
Published on 06/23/2026 at 19:47, 12 hours 23 minutes ago GROUPE SFPI: reorganisation de la Direction Générale
Published on 06/23/2026 at 19:47, 12 hours 23 minutes ago GROUPE SFPI: General management reorganisation
Published on 06/23/2026 at 19:10, 13 hours ago GUILLEMOT CORPORATION > EVOLUTION DE LA GOUVERNANCE A COMPTER DU 23 JUIN 2026
Published on 06/23/2026 at 19:10, 13 hours ago GUILLEMOT CORPORATION: Changes to Corporate Governance Effective June 23, 2026
Published on 06/23/2026 at 18:32, 13 hours 38 minutes ago Communiqué sur la demande de radiation auprès d'Euroclear des Droits à Complément de Prix
